Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine

NCT03777163 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
632
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Butantan Institute